Executive Viability Abstract
This feasibility study evaluates the implementation of an AI-driven digital healthcare diagnostic platform in India. With a focus on closing the diagnostic gap in Tier-2 and Tier-3 cities, the platform leverages deep learning for radiology and pathology analysis. The study confirms high financial viability supported by India's Ayushman Bharat Digital Mission (ABDM) and a rapidly growing HealthTech CAGR of 39%.
Return on Investment
145% over 5 years
Payback Span
3.2 Years
Net Present Value
$4.25 Million
IRR Index
27.4%
## Market Analysis
India's diagnostic market is valued at approximately $10 billion and is shifting toward digital-first models. The 'Digital India' initiative and increased smartphone penetration provide a fertile ground for AI diagnostics. Key drivers include a shortage of specialist radiologists (1 per 100,000 people) and the rising prevalence of chronic diseases.
## Capex Summary
The initial capital expenditure is estimated at $2.85 million. Major allocations include:
- **Infrastructure & Cloud (GPU-enabled):** $1.2M
- **AI Model Development & Training:** $0.85M
- **Regulatory Compliance & Certifications:** $0.3M
- **Initial Market Acquisition:** $0.5M
## Revenue Model
The platform utilizes a multi-tiered revenue strategy:
1. **B2B SaaS:** Subscription fees from private clinics and hospitals.
2. **B2C Pay-per-use:** Flat fee for AI-enhanced diagnostic reports for individual patients.
3. **B2G Partnerships:** Government contracts for rural screening programs.
4. **Data Insights:** Anonymized data licensing for pharmaceutical research.
## ROI Summary
Projected 5-year ROI stands at 145%. Scalability is achieved through low marginal costs per diagnostic test once the AI models are validated and deployed on edge-cloud architecture.